FDA NDC Directory · JSON-LD · Markdown

Buprenorphine

NDC 69238-1202 · HUMAN PRESCRIPTION DRUG · PATCH, EXTENDED RELEASE

Labeler / ManufacturerAmneal Pharmaceuticals NY LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA211586
Dosage form / routePATCH, EXTENDED RELEASE · TRANSDERMAL
Active ingredientsBUPRENORPHINE (5 ug/h)
Marketing started20200420
Package count1

External sources

Source: openFDA. Public-domain (CC0).